myDNA Merges with FamilyTree DNA #dna #announcements

Jan Meisels Allen



Australian genomics company, myDNA, announced a merger with the US based FamilyTree DNA, and its parent company Gene by Gene.  The CEO of myDNA, Dr. Lior Rauchberer will be the CEO of the merged companies.  Cofounders of Gene-by Gene Bennett Greenspan and Max Blankfield will join the board of directors.


The myDNA test is a functional pathology test that reports on how genetic factors may influence the ways in which medications affect individuals. Different people metabolize and eliminate medications differently, and at various speeds.

FamilyTree DNA is the first company in the United States to offer direct-to consumer DNA testing for genealogical research. It was founded in 2000.  My DNA was founded in 2007 with a mission to improve countless lives by revolutionizing the field of pharmacogenomics, making truly personalized medicine a reality, before expanding into nutrigenomics to deliver actionable, personalized nutrition, fitness and skincare recommendations.


According to the companies, At myDNA, consumer privacy is paramount. myDNA believes the importance of the consumer's ability to trust in the privacy of their genetic information, and retain control over it, cannot be overstated. Along the same line, Gene by Gene and FamilyTree DNA will continue acting in the field of Genetic Genealogy, their original business, keeping intact their privacy rules and all terms of service.


To read more see:


Jan Meisels Allen

Chairperson, IAJGS Public Records Access Monitoring Committee



Join to automatically receive all group messages.